Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
Nicaise EH, Schmeusser BN, Ali A, Midenberg E, Palacios AR, Hartsoe B, Kearns E, Ambadi S, Patil DH, Joshi SS, Narayan VM, Psutka SP, Nazha B, Brown JT, Ogan K, Bilen MA, Master VA. Nicaise EH, et al. Among authors: narayan vm. Clin Genitourin Cancer. 2024 Feb 16:102056. doi: 10.1016/j.clgc.2024.02.007. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38443295
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Sanda GE, Shabto JM, Goyal S, Liu Y, Martini DJ, Nazha B, Brown JT, Yantorni LB, Anne Russler G, Caulfield S, Joshi SS, Narayan VM, Kissick H, Ogan K, Master VA, Carthon BC, Kucuk O, Bilen MA. Sanda GE, et al. Among authors: narayan vm. Oncologist. 2023 Dec 11;28(12):1072-1078. doi: 10.1093/oncolo/oyad154. Oncologist. 2023. PMID: 37285524 Free PMC article.
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
Schmeusser BN, Biermann H, Nicaise EH, Ali AA, Patil DH, Midenberg E, Helman T, Armas-Phan M, Nabavizadeh R, Joshi SS, Narayan VM, Bilen MA, Psutka SP, Ogan K, Master VA. Schmeusser BN, et al. Among authors: narayan vm. Oncologist. 2023 Dec 11;28(12):e1219-e1229. doi: 10.1093/oncolo/oyad218. Oncologist. 2023. PMID: 37540787 Free PMC article.
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
Lotan Y, Agarwal P, Black P, Dickstein R, Kamat AM, Lee B, Narayan VM, Porten S, Psutka SP, Smith AK, Svatek RS, Williams SB, Woldu S. Lotan Y, et al. Among authors: narayan vm. Urol Oncol. 2024 Feb 1:S1078-1439(24)00020-6. doi: 10.1016/j.urolonc.2024.01.019. Online ahead of print. Urol Oncol. 2024. PMID: 38307803 Review.
Immunotherapy for advanced or metastatic urothelial carcinoma.
Maisch P, Hwang EC, Kim K, Narayan VM, Bakker C, Kunath F, Dahm P. Maisch P, et al. Among authors: narayan vm. Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD013774. doi: 10.1002/14651858.CD013774.pub2. Cochrane Database Syst Rev. 2023. PMID: 37811690 Review.
Mechanism of action of nadofaragene firadenovec-vncg.
Narayan VM, Meeks JJ, Jakobsen JS, Shore ND, Sant GR, Konety BR. Narayan VM, et al. Front Oncol. 2024 Mar 15;14:1359725. doi: 10.3389/fonc.2024.1359725. eCollection 2024. Front Oncol. 2024. PMID: 38559556 Free PMC article. Review.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J Jr, Lane BR, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Narayan VM, et al. J Urol. 2024 May 5:101097JU0000000000004020. doi: 10.1097/JU.0000000000004020. Online ahead of print. J Urol. 2024. PMID: 38704840
58 results